Skip to main content

Research Repository

Advanced Search

DAVID HEERY's Outputs (3)

Lipophilic activated ester prodrug approach for drug delivery to the intestinal lymphatic system (2018)
Journal Article
Lee, J. B., Zgair, A., Malec, J., Kim, T. H., Kim, M. G., Ali, J., Qin, C., Feng, W., Chiang, M., Gao, X., Voronin, G., Garces, A., Lau, C. L., Chan, T.-H., Hume, A., McIntosh, T. M., Soukarieh, F., Al-Hayali, M., Cipolla, E., Collins, H. M., …Gershkovich, P. (2018). Lipophilic activated ester prodrug approach for drug delivery to the intestinal lymphatic system. Journal of Controlled Release, 286, 10-19. https://doi.org/10.1016/j.jconrel.2018.07.022

The intestinal lymphatic system plays an important role in the pathophysiology of multiple diseases including lymphomas, cancer metastasis, autoimmune diseases, and human immunodeficiency virus (HIV) infection. It is thus an important compartment for... Read More about Lipophilic activated ester prodrug approach for drug delivery to the intestinal lymphatic system.

A fellowship of Ring1 maintains AML stem cells (2018)
Journal Article
Heery, D. M. (2018). A fellowship of Ring1 maintains AML stem cells. Blood, 131(16), 1771-1773. https://doi.org/10.1182/blood-2018-02-832121

Polycomb repressive complex 1 (PRC1) and PRC2 are transcriptional repressors that function as key regulators of the self-renewal and differentiation (cell lineage specification) pathways in stem cells. In this issue of Blood, Shima et al1 report that... Read More about A fellowship of Ring1 maintains AML stem cells.